miR-96 imposes its proliferative and anti-apoptotic effects via targeting Forkhead Box O1 (FOXO1), a known tumor suppressor in thyroid cancer [90] that is phosphorylated and subsequently degraded by PI3K/Akt activation [91]. This evidence concerns the gene AKT1 and thyroid gland carcinoma.